GTX-104 IV nimodipine shows improved outcomes in aSAH
A novel IV nimodipine (GTX-104) is described as delivering improved clinical outcomes and resource utilization versus oral nimodipine in aneurysmal subarachnoid hemorrhage (aSAH), with a stated strong safety profile.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.